Silence Therapeutics plc
Pharmaceutical Preparations · London
- PrincipalsRhonda Lynette HellumsChief Financial OfficerSteven J. RomanoEVP and Chief R&D Officerand 4 more
- CompanySilence Therapeutics plcLondon
Silence Therapeutics plc is an SEC-registered Nasdaq-listed company (ticker SLN) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chair & board
David LemusDirector (Board)
James Ede-GolightlyDirector (Board)
Timothy McInerneyDirector (Board)
Finance
Rhonda Lynette HellumsChief Financial Officer
Technology & engineering
Steven J. RomanoEVP and Chief R&D Officer
Everyone else on file (1)
Iain RossInterim PEO
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Rhonda Lynette Hellums — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Steven J. Romano — EVP and Chief R&D Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David Lemus — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Iain Ross — Interim PEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Silo Pharma, Inc.Pharmaceutical Preparations · Sarasota, FL, US1 shared capabilitySilexion Therapeutics CorpBiological Products, (No Diagnostic Substances) · Ramat Gan, IL1 shared capabilitySellas Life Sciences Group, Inc.Pharmaceutical Preparations · New York, NY, US1 shared capabilityJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilitySoligenix, Inc.Pharmaceutical Preparations · Princeton, NJ, US1 shared capabilitySionna Therapeutics, Inc.Pharmaceutical Preparations · Waltham, MA, US1 shared capabilityScilex Holding CoBiological Products, (No Diagnostic Substances) · Palo Alto, CA, US1 shared capabilitySyndax Pharmaceuticals IncPharmaceutical Preparations · New York, NY, US1 shared capability